Authors' recommendations: The recovered reports conclude that the scientific evidence available does not provide sufficient data to confirm potential benefits in terms of effectiveness and safety of the robotic surgery compared with conventional laparoscopic or open surgery.The acquisition of the system would involve an investment of 1.1-1.2 million Euros plus an annual maintenance of approximately one quarter of the purchase price of the robot. In the mitral valve surgery, the robotic system involved an increase in the total costs of 3,444$ compared with the conventional method (p=0,004), caused fundamentally by the increase in the intervention time. The intra-operative costs could be reduced because the operating theatre time reduces with increased experience on the part of the surgeons.

Project Status: Completed

URL for project: https://www.aetsa.org/publicacion/cirugia-robotica-mediante-el-sistema-de-telemanipulacion-robotica-da-vinci-en-la-cirugia-cardiovascular/

Year Published: 2010

URL for published report: https://www.aetsa.org/download/publicaciones/antiguas/AETSA-2007_23_Robot_Cardiovascular.pdf

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Spain

Organisation Name: Andalusian Health Technology Assessment Area

Contact Address: Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309

Contact Name: aetsa.csalud@juntadeandalucia.es

Contact Email: aetsa.csalud@juntadeandalucia.es

Copyright: Andalusian Agency for Health Technology Assessment (AETSA)